KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Other Non-Current Assets (2016 - 2025)

Teladoc Health (TDOC) has disclosed Other Non-Current Assets for 12 consecutive years, with $105.8 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 29.84% to $105.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $105.8 million through Dec 2025, up 29.84% year-over-year, with the annual reading at $105.8 million for FY2025, 29.84% up from the prior year.
  • Other Non-Current Assets hit $105.8 million in Q4 2025 for Teladoc Health, down from $106.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $108.8 million in Q1 2025 to a low of $17.9 million in Q3 2021.
  • Historically, Other Non-Current Assets has averaged $63.8 million across 5 years, with a median of $73.7 million in 2023.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 151.37% in 2021 and later decreased 4.9% in 2022.
  • Year by year, Other Non-Current Assets stood at $20.7 million in 2021, then soared by 134.46% to $48.5 million in 2022, then skyrocketed by 65.34% to $80.3 million in 2023, then grew by 1.53% to $81.5 million in 2024, then increased by 29.84% to $105.8 million in 2025.
  • Business Quant data shows Other Non-Current Assets for TDOC at $105.8 million in Q4 2025, $106.7 million in Q3 2025, and $101.1 million in Q2 2025.